Kaposi's sarcoma-associated herpesvirus induces rapid release of angiopoietin-2 from endothelial cells. 2013

Feng-Chun Ye, and Fu-Chun Zhou, and Stanley Nithianantham, and Bala Chandran, and Xiao-Lan Yu, and Aaron Weinberg, and Shou-Jiang Gao
Department of Biological Sciences, School of Dental Medicine, Case Western Reserve University, Cleveland, Ohio, USA. fxy63@case.edu

Kaposi sarcoma-associated herpesvirus (KSHV) stimulates proliferation, angiogenesis, and inflammation to promote Kaposi sarcoma (KS) tumor growth, which involves various growth factors and cytokines. Previously, we found that KSHV infection of human umbilical vein endothelial cells (HUVECs) induces a transcriptional induction of the proangiogenic and proinflammatory cytokine angiopoietin-2 (Ang-2). Here, we report that KSHV induces rapid release of Ang-2 that is presynthesized and stored in the Weibel-Palade bodies (WPB) of endothelial cells upon binding to its integrin receptors. Blocking viral binding to integrins inhibits Ang-2 release. KSHV binding activates the integrin tyrosine kinase receptor signaling pathways, leading to tyrosine phosphorylation of focal adhesion kinase (FAK), the tyrosine kinase Src, and the Calα2 subunit of the l-type calcium channel to trigger rapid calcium (Ca(2+)) influx. Pretreatment of endothelial cells with specific inhibitors of protein tyrosine kinases inhibits KSHV-induced Ca(2+) influx and Ang-2 release. Inhibition of Ca(2+) mobilization with calcium channel blockers also inhibits Ang-2 release. Thus, the interaction between KSHV and its integrin receptors plays a key role in regulating rapid Ang-2 release from endothelial cells. This finding highlights a novel mechanism of viral induction of angiogenesis and inflammation, which might play important roles in the early event of KS tumor development.

UI MeSH Term Description Entries
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012514 Sarcoma, Kaposi A multicentric, malignant neoplastic vascular proliferation characterized by the development of bluish-red cutaneous nodules, usually on the lower extremities, most often on the toes or feet, and slowly increasing in size and number and spreading to more proximal areas. The tumors have endothelium-lined channels and vascular spaces admixed with variably sized aggregates of spindle-shaped cells, and often remain confined to the skin and subcutaneous tissue, but widespread visceral involvement may occur. Kaposi's sarcoma occurs spontaneously in Jewish and Italian males in Europe and the United States. An aggressive variant in young children is endemic in some areas of Africa. A third form occurs in about 0.04% of kidney transplant patients. There is also a high incidence in AIDS patients. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, pp2105-7) HHV-8 is the suspected cause. Kaposi Sarcoma,Kaposi's Sarcoma,Multiple Idiopathic Pigmented Hemangiosarcoma,Kaposis Sarcoma,Sarcoma, Kaposi's
D016023 Integrins A family of transmembrane glycoproteins (MEMBRANE GLYCOPROTEINS) consisting of noncovalent heterodimers. They interact with a wide variety of ligands including EXTRACELLULAR MATRIX PROTEINS; COMPLEMENT, and other cells, while their intracellular domains interact with the CYTOSKELETON. The integrins consist of at least three identified families: the cytoadhesin receptors (RECEPTORS, CYTOADHESIN), the leukocyte adhesion receptors (RECEPTORS, LEUKOCYTE ADHESION), and the VERY LATE ANTIGEN RECEPTORS. Each family contains a common beta-subunit (INTEGRIN BETA CHAINS) combined with one or more distinct alpha-subunits (INTEGRIN ALPHA CHAINS). These receptors participate in cell-matrix and cell-cell adhesion in many physiologically important processes, including embryological development; HEMOSTASIS; THROMBOSIS; WOUND HEALING; immune and nonimmune defense mechanisms; and oncogenic transformation. Integrin
D042702 Angiopoietin-2 An angiopoietin that is closely related to ANGIOPOIETIN-1. It binds to the TIE-2 RECEPTOR without receptor stimulation and antagonizes the effect of ANGIOPOIETIN-1. However its antagonistic effect may be limited to cell receptors that occur within the vasculature. Angiopoietin-2 may therefore play a role in down-regulation of BLOOD VESSEL branching and sprouting. Angiopoietin 2
D042783 Endothelial Cells Highly specialized EPITHELIAL CELLS that line the HEART; BLOOD VESSELS; and lymph vessels, forming the ENDOTHELIUM. They are polygonal in shape and joined together by TIGHT JUNCTIONS. The tight junctions allow for variable permeability to specific macromolecules that are transported across the endothelial layer. Capillary Endothelial Cells,Lymphatic Endothelial Cells,Vascular Endothelial Cells,Capillary Endothelial Cell,Cell, Capillary Endothelial,Cell, Endothelial,Cell, Lymphatic Endothelial,Cell, Vascular Endothelial,Cells, Capillary Endothelial,Cells, Endothelial,Cells, Lymphatic Endothelial,Cells, Vascular Endothelial,Endothelial Cell,Endothelial Cell, Capillary,Endothelial Cell, Lymphatic,Endothelial Cell, Vascular,Endothelial Cells, Capillary,Endothelial Cells, Lymphatic,Endothelial Cells, Vascular,Lymphatic Endothelial Cell,Vascular Endothelial Cell
D051416 Focal Adhesion Protein-Tyrosine Kinases A family of non-receptor, PROLINE-rich protein-tyrosine kinases. Focal Adhesion Protein-Tyrosine Kinase Family,Focal Adhesion Kinase,Focal Adhesion Protein-Tyrosine Kinase,Focal Adhesion Protein Tyrosine Kinase Family,Focal Adhesion Protein Tyrosine Kinases
D019288 Herpesvirus 8, Human A species in the genus RHADINOVIRUS, subfamily GAMMAHERPESVIRINAE, isolated from patients with AIDS-related and "classical" Kaposi sarcoma. Herpesvirus, Kaposi Sarcoma-Associated,KSHV,Kaposi Sarcoma-Associated Herpesvirus,HHV-8,Herpesvirus, Kaposi's Sarcoma-Associated,Human Herpesvirus 8,Kaposi's Sarcoma-Associated Herpesvirus,Herpesvirus, Kaposi Sarcoma Associated,Herpesvirus, Kaposi's Sarcoma Associated,Herpesvirus, Kaposis Sarcoma-Associated,Herpesviruses, Kaposi's Sarcoma-Associated,Kaposi Sarcoma Associated Herpesvirus,Kaposi's Sarcoma Associated Herpesvirus,Kaposi's Sarcoma-Associated Herpesviruses,Kaposis Sarcoma-Associated Herpesvirus,Sarcoma-Associated Herpesvirus, Kaposi,Sarcoma-Associated Herpesviruses, Kaposi's

Related Publications

Feng-Chun Ye, and Fu-Chun Zhou, and Stanley Nithianantham, and Bala Chandran, and Xiao-Lan Yu, and Aaron Weinberg, and Shou-Jiang Gao
October 2004, Virology,
Feng-Chun Ye, and Fu-Chun Zhou, and Stanley Nithianantham, and Bala Chandran, and Xiao-Lan Yu, and Aaron Weinberg, and Shou-Jiang Gao
December 1995, Nature medicine,
Feng-Chun Ye, and Fu-Chun Zhou, and Stanley Nithianantham, and Bala Chandran, and Xiao-Lan Yu, and Aaron Weinberg, and Shou-Jiang Gao
March 2020, Journal of virology,
Feng-Chun Ye, and Fu-Chun Zhou, and Stanley Nithianantham, and Bala Chandran, and Xiao-Lan Yu, and Aaron Weinberg, and Shou-Jiang Gao
May 2007, Cancer research,
Feng-Chun Ye, and Fu-Chun Zhou, and Stanley Nithianantham, and Bala Chandran, and Xiao-Lan Yu, and Aaron Weinberg, and Shou-Jiang Gao
August 1998, Nature,
Feng-Chun Ye, and Fu-Chun Zhou, and Stanley Nithianantham, and Bala Chandran, and Xiao-Lan Yu, and Aaron Weinberg, and Shou-Jiang Gao
February 2011, Journal of dermatological science,
Feng-Chun Ye, and Fu-Chun Zhou, and Stanley Nithianantham, and Bala Chandran, and Xiao-Lan Yu, and Aaron Weinberg, and Shou-Jiang Gao
June 2008, Cancer research,
Feng-Chun Ye, and Fu-Chun Zhou, and Stanley Nithianantham, and Bala Chandran, and Xiao-Lan Yu, and Aaron Weinberg, and Shou-Jiang Gao
January 1997, Journal of virology,
Feng-Chun Ye, and Fu-Chun Zhou, and Stanley Nithianantham, and Bala Chandran, and Xiao-Lan Yu, and Aaron Weinberg, and Shou-Jiang Gao
May 2000, Microbes and infection,
Feng-Chun Ye, and Fu-Chun Zhou, and Stanley Nithianantham, and Bala Chandran, and Xiao-Lan Yu, and Aaron Weinberg, and Shou-Jiang Gao
March 1998, AIDS (London, England),
Copied contents to your clipboard!